Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tison

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Vnitrni Lekarstvi|June 14, 2002
[Are we underestimating the nephrotoxicity of drugs?]J Tisonová, B Biss, P Tison, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserinR Dzúrik, N Fetkovská, G Brimichová, et al.
Casopis Lekaru Ceskych|March 16, 1984
[Serotonin antagonists in the treatment of hypertension]N Fetkovská, G Brimichová, P Tison, et al.
Bratislavske Lekarske Listy|January 1, 1985
[Clinicopharmacologic aspects of the effects of serotonin and its blockade]R Dzúrik, N Fetkovská, G Brimichová, et al.
Nephron|January 1, 1983
Influence of inhibitor of glucose utilization on the blood platelet functionP Tison, P Kubisz, P Cernácek, et al.
Czechoslovak Medicine|January 1, 1984
Acute effects of antagonist of S2-receptorsN Petkovská, G Brimichová, P Tison, et al.
Vnitrni Lekarstvi|November 1, 1974
[Importance of spironolactone in the diuretic treatment]V Dzúriková, P Tison, V Revúsová, et al.
Nephron|January 1, 1981
Uremic 'toxins' and blood platelet carbohydrate metabolismP Tison, P Cernácek, E Silvánová, et al.
Blood Pressure. Supplement|January 1, 1994
Treatment of hypertension with dihydropyridine calcium antagonists and aspirinP Tison, L Ulicna, Z Jakubovska, et al.
American Journal of Hypertension|July 1, 1994
Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertensionP Tison, L Ulicna, Z Jakubovska, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|June 14, 2002
[Are we underestimating the nephrotoxicity of drugs?]J Tisonová, B Biss, P Tison, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserinR Dzúrik, N Fetkovská, G Brimichová, et al.
Casopis Lekaru Ceskych|March 16, 1984
[Serotonin antagonists in the treatment of hypertension]N Fetkovská, G Brimichová, P Tison, et al.
Bratislavske Lekarske Listy|January 1, 1985
[Clinicopharmacologic aspects of the effects of serotonin and its blockade]R Dzúrik, N Fetkovská, G Brimichová, et al.
Nephron|January 1, 1983
Influence of inhibitor of glucose utilization on the blood platelet functionP Tison, P Kubisz, P Cernácek, et al.
Czechoslovak Medicine|January 1, 1984
Acute effects of antagonist of S2-receptorsN Petkovská, G Brimichová, P Tison, et al.
Vnitrni Lekarstvi|November 1, 1974
[Importance of spironolactone in the diuretic treatment]V Dzúriková, P Tison, V Revúsová, et al.
Nephron|January 1, 1981
Uremic 'toxins' and blood platelet carbohydrate metabolismP Tison, P Cernácek, E Silvánová, et al.
Blood Pressure. Supplement|January 1, 1994
Treatment of hypertension with dihydropyridine calcium antagonists and aspirinP Tison, L Ulicna, Z Jakubovska, et al.
American Journal of Hypertension|July 1, 1994
Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertensionP Tison, L Ulicna, Z Jakubovska, et al.
Pageof 4